| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Lonza Group Ltd (SW: LONN)
LONN Technical Analysis
5
| As on 24th Jan 2025 LONN STOCK Price closed @ 591.00 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 441.30 & Strong Buy for SHORT-TERM with Stoploss of 449.72 we also expect STOCK to react on Following IMPORTANT LEVELS. |
LONNSTOCK Price
| Open | 586.60 | Change | Price | % |
| High | 591.00 | 1 Day | 7.80 | 1.34 |
| Low | 582.00 | 1 Week | 46.80 | 8.60 |
| Close | 591.00 | 1 Month | 71.00 | 13.65 |
| Volume | 152187 | 1 Year | 102.00 | 20.86 |
| 52 Week High 587.40 | 52 Week Low 311.50 | ||||
SW Switzerland Most Active Stocks
| CSGN | 0.82 | 0.00% |
| CSGN | 0.82 | 0.00% |
| UBSG | 31.84 | 0.44% |
| UBSG | 31.84 | 0.44% |
| NESN | 74.68 | -0.03% |
| NESN | 74.68 | -0.03% |
| NOVN | 90.26 | 0.00% |
| NOVN | 90.26 | 0.00% |
| ABBN | 54.00 | 0.78% |
| ABBN | 54.00 | 0.78% |
SW Switzerland Top Gainers Stocks
SW Switzerland Top Losers Stocks
| LONN Daily Charts |
LONN Intraday Charts |
Whats New @ Bazaartrend |
LONN Free Analysis |
|
|
LONN Important Levels Intraday
| RESISTANCE | 608.34 |
| RESISTANCE | 602.78 |
| RESISTANCE | 599.34 |
| RESISTANCE | 595.91 |
| SUPPORT | 586.10 |
| SUPPORT | 582.66 |
| SUPPORT | 579.22 |
| SUPPORT | 573.66 |
LONN Forecast January 2025
| 4th UP Forecast | 934.01 |
| 3rd UP Forecast | 824 |
| 2nd UP Forecast | 756.01 |
| 1st UP Forecast | 688.01 |
| 1st DOWN Forecast | 493.99 |
| 2nd DOWN Forecast | 425.99 |
| 3rd DOWN Forecast | 358 |
| 4th DOWN Forecast | 247.99 |
LONN Weekly Forecast
| 4th UP Forecast | 630.12 |
| 3rd UP Forecast | 617.57 |
| 2nd UP Forecast | 609.82 |
| 1st UP Forecast | 602.06 |
| 1st DOWN Forecast | 579.94 |
| 2nd DOWN Forecast | 572.18 |
| 3rd DOWN Forecast | 564.43 |
| 4th DOWN Forecast | 551.88 |
LONN Forecast2025
| 4th UP Forecast | 1135.18 |
| 3rd UP Forecast | 960.66 |
| 2nd UP Forecast | 852.78 |
| 1st UP Forecast | 744.91 |
| 1st DOWN Forecast | 437.09 |
| 2nd DOWN Forecast | 329.22 |
| 3rd DOWN Forecast | 221.34 |
| 4th DOWN Forecast | 46.82 |
Lonza Group Ltd ( SW Switzerland Symbol : LONN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
LONN Business Profile
Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and specialty ingredients markets worldwide. The company operates through two segments, Pharma Biotech & Nutrition, and Specialty Ingredients. The Pharma Biotech & Nutrition segment provides technology platforms, including drug substance and drug product; and develops and manufactures customized active pharmaceutical ingredients and biopharmaceuticals, as well as formulation services and delivery systems for pharmaceutical and nutritional applications. It serves pharmaceutical companies, biotechnology firms, and medical research and testing organizations, as well as consumer health and nutrition companies. The Specialty Ingredients segment engages in the microbial control solutions and specialty chemical services businesses. Its Microbial control solutions business has offerings in professional hygiene, and home and personal care markets; and offerings in paints and coating, wood protection, material protection, and crop protection. This segment also offers specialty chemicals in electronics, aerospace, food and feed ingredients, agrochemicals, and diversified specialty chemicals markets. The company has a strategic collaboration agreement with Moderna, Inc. to manufacture a potential COVID-19 vaccine, mRNA-1273; and CellPoint B.V to deliver CAR-T cells to patients at point-of-care. Lonza Group Ltd was founded in 1897 and is headquartered in Basel, Switzerland. Address: Muenchensteinerstrasse 38, Basel, Switzerland, 4002
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service